Sellas Life Sciences
SLS
$1.35
Share price
5.47%
Change (1 day)
-8.16%
Change (1 year)
Categories
Sellas Life Sciences (SLS) - Total debt
Total debt on the balance sheet as of December 2023 : $0.9 M
According to Sellas Life Sciences's latest financial reports the company's total debt is $0.9 M. A company’s total debt is the sum of all current and non-current debts.
Sellas Life Sciences - Total debt on balance sheet (from 2008 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.94 M | 16.96% |
| 2021-12-31 | $0.8 M | -18.47% |
| 2020-12-31 | $0.99 M | 356.68% |
| 2019-12-31 | $0.21 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $10.98 M | 49.13% |
| 2016-12-31 | $7.36 M | 55.48% |
| 2015-12-31 | $4.73 M | -43.6% |
| 2014-12-31 | $8.4 M | -15.06% |
| 2013-12-31 | $9.89 M | 17254.39% |
| 2012-12-31 | $0.05 M | -89.95% |
| 2011-12-31 | $0.56 M | 698.59% |
| 2010-12-31 | $0.07 M | -19.32% |
| 2009-12-31 | $0.08 M | 319.05% |
| 2008-12-31 | $0.02 M | |
| 2006-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | 203.75% | 🇺🇸 USA |